Antimicrobial-impregnated Sutures Reduce Surgical Site Infections in Plastic Surgery: A Systematic Review and Meta-analysis Authors: Sarah Petrecca, Simran K. Chandawarkar, Hassan ElHawary, Rawan Elabd, Jeffrey E. Janis Published: 2026 ABSTRACT Background:Surgical site infections (SSIs) are a common complication in plastic surgery, contributing to increased morbidity, prolonged recovery, and increased healthcare costs. Antimicrobial-impregnated sutures (AISs) have shown promise in reducing SSI rates across surgical disciplines. However, their efficacy in plastic surgery remains unclear.Methods:This review followed PRISMA (Preferred Reporting Items of Systematic Reviews and Meta-Analysis) 2020 guidelines. PubMed and Web of Science were searched for comparative studies assessing AIS use. Seven studies were identified. Data extracted included patient demographics, study variables, and postoperative outcomes. SSI rates were pooled using a random-effects model and reported as a risk ratio (RR) with 95% confidence intervals (CIs). Analyses of wound healing/outcomes were performed using Fisher exact tests.Results:In a pool of 1553 patients (807 intervention, 746 control), AIS use was associated with a significant reduction in SSIs (RR 0.68, 95% CI [0.51–0.90], P = 0.0066). This effect was pronounced in abdominal surgery (RR 0.51, 95% CI [0.35–0.74], P = 0.0004) but not significant in breast surgery (RR 0.71, 95% CI [0.44–1.15], P = 0.1657). AISs significantly improved cosmetic outcomes (RR 0, 95% CI [0–0.2058], P < 0.0001).Conclusions:AISs are associated with improved postoperative outcomes, particularly in reducing incidence of SSIs and improving cosmetic outcomes. Although these findings support the use of AISs in plastic surgery procedures, randomized controlled trials comparing antimicrobial agents and their use in different anatomical areas are warranted to establish definitive clinical guidelines. Takeaways Question: Are antibiotic-impregnated sutures (AISs) efficacious in plastic surgery? Findings: AIS use was associated with a significant reduction in surgical site infections (SSIs) (8.6% versus 13.8%, P = 0.0016). This effect was particularly pronounced in abdominal surgery (P = 0.0003), but not statistically significant in breast surgery (P = 0.2656). AISs also significantly reduced poor wound healing outcomes (P < 0.0001). No significant difference was observed in wound dehiscence rates (P = 0.156). Meaning: AISs are associated with improved postoperative outcomes in plastic surgery, particularly in reducing SSIs and enhancing wound healing. INTRODUCTION Surgical site infections (SSIs) are a known complication in plastic surgery operations, affecting approximately 5% of patients and contributing to up to 20% of healthcare-associated infections.1 In the United States, SSIs pose a significant financial burden, costing an estimated $3.3–$10 billion annually.2 These infections can negatively impact patient outcomes by increasing morbidity, mortality, and healthcare costs for both patients and institutions. The Centers for Disease Control and Prevention classifies SSIs into superficial, deep, and organ/space infections,3 with specific criteria guiding classification3 (Table 1). Sutures can serve as a nidus for bacterial colonization, allowing pathogens, most commonly Staphylococcus aureus and Pseudomonas aeruginosa, to adhere to sutures and form biofilms that are notoriously resistant to treatment.4 Factors such as suture type, surgical technique, and drain placement have been shown to be implicated in superficial SSIs.5 Given that prevention is more effective than treatment, it is important to mitigate biofilm formation from the outset. Table 1.Centers for Disease Control and Prevention Criteria for the Classification of SSIsSSICriteriaSuperficial incisional SSI1. Occurs within 30 d postoperatively2. Affects the skin and subcutaneous tissue onlyAt least one of the following:A. Purulent discharge from the surgical siteB. Organisms isolated from a culture of the surgical siteC. Signs or symptoms of infection: swelling, erythema, or localized pain or warmthD. Diagnosis of a superficial incisional SSI by the surgeonDeep incisional SSI1. Occurs within 30 d postoperatively if no implant is used, or within 1 y if an implant is in place2. Involves deep tissues (fascial and muscle layers).At least one of the following:A. Purulent drainage from the surgical siteB. Wound dehiscenceC. Deliberate opening of the incision by the surgeon due to suspicion of infection, or spontaneous wound dehiscence, and a positive wound culture and at least 1 infectious symptom present (fever, localized pain, tenderness)D. An abscess or other evidence of infection is found on CT scanOrgan space incisional SSI1. May involve any organ or anatomical space, but deeper than the fascial or muscle layersAt least one of the following:A. Presence of purulent discharge from a drain placed in the organ, space, or cavityB. Organisms isolated from a cultureC. Evidence of abscess formation or infection involving the organ, cavity, or anatomical space, as observed on a CT scanCT, computed tomography. Centers for Disease Control and Prevention Criteria for the Classification of SSIs CT, computed tomography. Antibiotic-impregnated sutures (AISs) are commonly coated with triclosan, a broad-spectrum antimicrobial effective against Gram-positive, Gram-negative, and fungal organisms. Triclosan reduces bacterial colonization on the suture surface by inhibiting lipid synthesis within the bacterial cell membrane (Fig. 1). Since their introduction, various AIS types have become available for perioperative use, including absorbable, nonabsorbable, monofilament, and braided sutures.6 Schematic diagram illustrating the effect of AISs in preventing biofilm formation. Across several specialties, AISs have shown to be useful in reducing bacterial infection. For example, in oral surgery, triclosan-coated AISs were found to be successful in reducing SSIs, specifically by reducing bacterial growth.7 Similarly, their use in spinal surgery showed a significant reduction in infection rates.8 In contrast, a study in head and neck surgery reported no significant difference in SSI rates between triclosan-coated AISs and control groups, highlighting the need for more evidence and specialty-specific research on AIS efficacy.9 In plastic surgery, the risk of SSIs may be increased with prolonged operative times and the involvement of extensive soft tissue manipulation in certain procedures.10 Furthermore, the strong emphasis placed on aesthetic outcomes makes infection-related complications particularly devastating. As a result, many plastic surgeons have adopted AISs to reduce SSI incidence. Despite this, the current body of literature on AIS use in plastic surgery remains limited, and their overall effectiveness in this specialty is unclear. The goal of this review is to synthesize the existing literature on AISs in plastic surgery to guide optimal patient care and identify future directions of research. METHODS Eligibility Criteria This systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items of Systematic Reviews and Meta-Analysis) guidelines and registered in PROSPERO (CRD420251148549). We assessed the use of AISs in patients undergoing plastic surgery–associated procedures (defined as procedures that are commonly performed by plastic surgeons) and the associated postoperative outcomes and complications. Studies that evaluated the efficacy of AISs were pooled for the review process. Search Strategy The search was conducted from inception to December 2024, using the PubMed and Web of Science databases with the following search strategy: “(antimicrobial suture OR anti-microbial sutures OR anti-bacterial suture or triclosan coated OR triclosan-coated OR vicryl plus OR antibacterial suture) AND (plastic surgery OR plastic OR reconstructive OR aesthetic OR Cosmetic).” After the removal of duplicates, article titles and abstracts were screened independently by 2 authors (S.P. and S.K.C.). Conflicts were resolved by the third author (H.E.). Inclusion criteria included all comparative clinical studies that assessed the efficacy of AISs in plastic surgery–associated procedures. Exclusion criteria included noncomparative studies, nonclinical studies, animal studies, biotechnological studies, nonplastic surgery cases, and studies written in a language other than English. The selected full-text articles underwent a second screening by the same 2 authors using the same inclusion and exclusion criteria. Data Collection Data collected included study type, patient demographic variables, operation type, wound type, surgical anatomical area, and type of suture and antimicrobial agent used. Surgical outcomes such as SSIs and wound healing/cosmetic outcomes were included. The relevant information is summarized in a database (Table 2). Table 2.Summary of ResultsAuthors (Year of Publication)Type of StudyLevel of EvidenceNo. Included PatientsSex (Males Versus Females)Mean Reported Age, yType of WoundAnatomical AreaMean Follow-upOperation TypeType of SutureType of Antimicrobial UsedSSIPoor Wound HealingBerrevoet (2024)11Retrospective cohort studyIIB821N/AN/ACleanAbdomen30, 60, 90 dOpen hernia repairIntervention446222 M; 224 F61.8CleanAbdomen30, 60, and 90 dOpen hernia repairTriclosan-coated barbed suture (STRATAFIX Symmetric [TCS; Ethicon])Triclosan5.9% (n = 26)N/AControl375196 M; 179 F61.3CleanAbdomen30, 60, and 90 dOpen hernia repairConventional PDS suture (non-PLUS)None11.7% (n = 44)N/ACarella (2019)12Double-blinded RCTIB366 M; 30 F44CleanBreast and skin (nonspecific)1 and 3 wk; 1, 3, 6, and 13 moBilateral mammary surgery and skin lesions removalIntervention18N/AN/ACleanBreast and skin (nonspecific)1 and 3 wk; 1, 3, 6, and 13 moBilateral mammary surgery and skin lesions removalCoated monofilament absorbable with chlorhexidine (Monofil Plus, Assut Europe)Chlorhexidine0%0%Control18N/AN/ACleanBreast and skin (nonspecific)1 and 3 wk; 1, 3, 6, and 13 moBilateral mammary surgery and skin lesions removalUncoated standard absorbable sutureNone0%44% (n = 8)Wormald (2023)13RCTIB116N/AN/AN/AHand, wrist30 and 90 dSurgery post hand traumaIntervention6046 M; 14 F44.840 open, 36 contaminated, 4 dirty, 19 closedHand, wrist30 and 90 dSurgery post hand traumaEthicon (Monocryl Plus, PDS Plus), antimicrobial suturesTriclosan13.3% (n = 8)N/AControl5636 M; 20 F47.240 open, 36 contaminated, 4 dirty, 19 closedHand, wrist30 and 90 dSurgery post hand traumaNonantimicrobial suturesNone12.5% (n = 7)N/AChen (2011)9RCTIB241N/AN/AClean contaminated (by normal flora of oral cavity)Head and neck2 wkHead and neck cancer excisionIntervention112105 M; 7 F53.6Clean contaminated (by normal flora of oral cavity)Head and neck2 wkHead and neck cancer excision3-0 triclosan-coated polyglactin 910 sutures (Vicryl Plus; Ethicon)Triclosan14.9% (n = 17)N/AControl129120 M; 9 F51.1Clean contaminated (by normal flora of oral cavity)Head and neck2 wkHead and neck cancer excision3-0 polyglactin 910 suturesNone14.7% (n = 19)N/AZhang (2011)14RCTIB89N/AN/ACleanBreast3, 5, 6, 12, 30, and 90 dBreast cancer surgeryIntervention4647 F51CleanBreast3, 5, 6, 12, 30, and 90 dBreast cancer surgeryVicryl Plus antibacterial (polyglactin 910)Triclosan4.3% (n = 2)0%Control4346 F52CleanBreast3, 5, 6, 12, 30, and 90 dBreast cancer surgeryChinese silk sutureNone11.6% (n = 5)25.5% (n = 11)Singh (2024)15RCTIB100N/AN/AN/AAbdomen2, 5, 7, 14, 21, and 30 dAbdominal wound closureIntervention5028 M; 22 F42.146 clean, 30 clean contaminated, 14 contaminatedAbdomen2, 5, 7, 14, 21, and 30 dAbdominal wound skin closurePolyglactin 910 coated with triclosanTriclosan20% (n = 10)0%Control5029 M; 21 F43.37 clean, 30 clean contaminated, 13 contaminatedAbdomen2, 5, 7, 14, 21, and 30 dAbdominal wound skin closureNormal sutureNone38% (n = 19)4% (n = 2)Williams (2011)16RCTIBCleanBreast2 and 6 wkBreast cancer surgeryIntervention7575 F61CleanBreast2 and 6 wkBreast cancer surgeryVicryl/Monocryl PlusTriclosan25% (n = 19)N/AControl7575 F59CleanBreast2 and 6 wkBreast cancer surgeryVicryl/Monocryl standardNone33% (n = 25)N/ANA, not available. Summary of Results NA, not available. The risk of bias for nonrandomized studies was assessed using the Cochrane Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I). The domains included bias from (1) confounding, (2) selection of participants, (3) classification of interventions, (4) deviations from intended interventions, (5) missing data, (6) measurement of outcomes, and (7) selection of the reported result. The risk of bias for each randomized controlled trial (RCT) was assessed using the Cochrane Risk of Bias 2 (ROB 2) tool. The domains included bias from (1) randomization, (2) deviations from intended interventions, (3) missing outcome data, (4) measurement of the outcomes, and (5) selection of reported results. Data Analyses Demographic variables such as the distribution of wound types was compared using the Fisher exact test. This analysis was performed using GraphPad Prism 10.0. A pooled analysis of outcomes reported by at least 2 studies was performed. This included SSIs and wound healing/cosmetic outcomes. For SSIs, meta-analysis was conducted to compute the risk ratio (RR) and the 95% confidence intervals (CIs) using a random-effects model to account for heterogeneity (I2 > 25%). These analyses were performed using a web-based tool.17 For wound healing/cosmetic outcomes, Fisher exact tests were performed using GraphPad Prism 10.0. Post hoc power assessments were performed for all pooled data. A P value of less than 0.05 was predetermined as statistically significant. RESULTS Study Selection and Quality Assessment Our search identified 705 articles. No duplicates were identified. Title and abstract screening resulted in 45 eligible articles that underwent full-text screening; among them, 7 fit the inclusion criteria9,11–15 (Fig. 2). Six of the selected articles were RCTs9,12–16 of level IB evidence,18 whereas the remaining article was a retrospective cohort study11 of level IIB evidence18 (Table 2). PRISMA diagram for screening and study inclusion. Characteristics of the Included Studies A total of 1553 patients underwent a plastic surgery–associated procedure (defined as a procedure that is commonly performed by plastic surgeons). Of the 1553 patients, 807 of them underwent a surgical procedure using AISs (intervention group), whereas 746 underwent a surgical procedure using standard sutures (control group). The average patient age was 57 in the intervention group versus 56 in the control group. The patient population included 788 men and 769 women. Comprehensive study characteristics are presented in Table 2. The distribution of wound types in the intervention group was as follows: 591 clean, 142 clean contaminated, 50 contaminated, and 4 dirty; whereas in the control group, it was as follows: 518 clean, 159 clean contaminated, 49 contaminated, and 4 dirty. Surgical procedures included hernia repairs,11 breast surgery,12 skin lesion excision,12 hand trauma reconstruction,13 head and neck cancer resection,9 breast cancer surgery,14,16 wound closure,15 and breast reduction.19 Anatomical areas included the abdomen,11,15 breast,12,14 hand and wrist,13 and head and neck.9 Specific suture types used in the intervention procedures in their respective studies included triclosan-coated barbed suture (Stratafix Symmetric [TCS; Ethicon]),11 triclosan-coated monofilament suture (Monocryl, Plus, polydioxanone [PDS] Plus),13 chlorohexidine-coated monofilament absorbable suture (Monofil Plus; Assut Europe, Italy),12 and triclosan-coated polyglactin 910 sutures (Vicryl Plus; Ethicon).9,14–16 The 2 antimicrobial agents were triclosan and chlorhexidine. Sutures used in the control procedures included conventional PDS sutures (non-PLUS),11 uncoated standard absorbable sutures,12 nonantimicrobial sutures,13,15 polyglactin 910 sutures,9,16 and Chinese silk sutures.14 Postoperative follow-up time ranged from 3 days to 12 months (mean 84 d). Postoperative complications, such as SSIs, and wound healing/cosmetic outcomes were assessed during follow-up sessions. SSI Outcomes A total of 1553 patients were included in the pooled analysis of SSI complications. Approximately half of them (n = 807; 51.9%) underwent surgery with AISs, whereas the remaining patients (n = 746; 48%) underwent surgery with standard sutures. SSIs occurred in 82 (10.1%) patients in the intervention group, and in 119 (15.9%) patients in the control group. Pooled analysis demonstrated that AISs significantly reduced SSIs postoperatively (RR 0.68, 95% CI [0.51–0.90], P = 0.0066, I2 = 13%, power = 92.5%) (Fig. 3A). Further subanalysis revealed that AISs significantly decreased SSI incidence in abdominal surgery (RR 0.51, 95% CI [0.35–0.74], P = 0.0004, I2 = 0%, power = 95.6%) (Fig. 3B). However, no significant differences were found in breast surgery (RR 0.71, 95% CI [0.44–1.15], P = 0.16, I2 = 0%, power = 31.6%) (Fig. 3). Pooled analysis of SSI rates in antibiotic-coated and control sutures. A, Pooled analysis of all studies. B, Pooled analysis of abdominal studies. C, Pooled analysis of breast studies. Meta-analysis using a random-effects model with the Mantel–Haenszel method to compare RRs and account for heterogeneity (I2). IV, inverse-variance. Wound Cosmetic Outcomes Wound cosmetic outcomes were evaluated in 3 studies.12,14,15 Endpoints assessed included color and size of the scar, as well as overall aesthetic appearance. A total of 225 patients were included in the pooled analysis of cosmetic outcomes. Approximately half (n = 114; 50.6%) underwent surgery with AISs, whereas the remainder (n = 111; 49.3%) underwent surgery with standard sutures. Poor cosmesis occurred in none of the patients in whom AISs were used and in 21 patients in whom standard sutures were used. Fisher exact test analysis demonstrated that AIS use was associated with a reduction in poor cosmetic outcomes (P < 0.0001, power 100%) (Fig. 4). Cosmetic outcomes were not assessed in the remaining 4 studies of this review.9,13 Pooled analysis of wound healing rates in antibiotic-coated and control sutures. Fisher exact test. Significance P < 0.05. Risk of Bias A risk of bias assessment was performed to assess the validity and reliability of the studies included in this review (Tables 3, 4). The nonrandomized study was assessed using the ROBINS-I tool and was found to be at moderate risk of bias, with concerns regarding possible confounding variables. All other domains of bias were of low risk. Of the RCTs included in this review, 3 studies were rated as low risk of bias13,14,16 and 3 had some concerns9,12,15 based on the Cochrane ROB 2 tool. These concerns stemmed from unclear randomization process. All studies had a low concern for bias arising from deviations from the intended interventions and measurement of outcomes. Table 3.Risk of Bias Assessment Using the Cochrane ROBINS-IAuthors (Year of Publication)D1D2D3D4D5D6D7OverallBerrevoet (2024)11Moderate riskLow riskLow riskLow riskLow riskLow riskLow riskModerate riskDomains included bias from (D1) confounding, (D2) selection of participants, (D3) classification of interventions, (D4) deviations from intended interventions, (D5) missing data, (D6) measurement of outcomes, and (7) selection of the reported result. Risk of Bias Assessment Using the Cochrane ROBINS-I Domains included bias from (D1) confounding, (D2) selection of participants, (D3) classification of interventions, (D4) deviations from intended interventions, (D5) missing data, (D6) measurement of outcomes, and (7) selection of the reported result. Table 4.Risk of Bias Assessment Using the Cochrane ROB 2 ToolAuthors (Year of Publication)D1D2D3D4D5OverallCarella (2019)12Some concernsLow riskSome concernLow riskSome concernSome concernWormald (2023)13Low riskLow riskLow riskLow riskLow riskLow riskChen (2011)9Some concernLow riskLow riskLow riskLow riskSome concernZhang (2011)14Low riskLow riskLow riskLow riskLow riskLow riskSingh (2024)15Some concernLow riskLow riskLow riskLow riskSome concernWilliams (2011)16Low riskLow riskLow riskLow riskLow riskLow riskDomains included bias from (D1) randomization process, (D2) deviations from the intended interventions, (D3) missing outcome data, (D4) measurement of the outcomes, and (D5) selection of reported results. Risk of Bias Assessment Using the Cochrane ROB 2 Tool Domains included bias from (D1) randomization process, (D2) deviations from the intended interventions, (D3) missing outcome data, (D4) measurement of the outcomes, and (D5) selection of reported results. DISCUSSION This systematic review and meta-analysis demonstrates that AISs are effective in improving postoperative outcomes of plastic surgery–associated procedures. Indeed, AISs significantly reduced the risk of SSIs and poor cosmetic outcomes. These findings are consistent with prior research in other surgical disciplines such as general20–22 and cardiac23 surgery, where AISs have shown a benefit in lowering infection risk. Interestingly, our results demonstrate that the use of AISs is associated with a significant risk reduction of SSIs in abdominal surgery compared with a nonsignificant risk reduction in breast surgery. All breast procedures were performed in clean fields, whereas some of the abdominal procedures were performed in clean-contaminated and contaminated fields. This is consistent with published literature highlighting that abdominal procedures have much higher rates of SSIs than any other type of surgical procedures.24–27 We suggest that because this anatomical area has an increased baseline SSI risk, there is greater potential for these procedures to benefit from antimicrobial interventions such as AISs, which could provide a rationale for the significant risk reduction observed. Although our results demonstrate that AISs lead to a significant reduction in poor wound cosmetic outcomes, only 3 of the 7 studies assessed this endpoint. Given that our results demonstrate a reduction in infection rates with AISs, and that infections can lead to poor wound outcomes, it is likely that our results are valid. However, the effects of antibiotic coating on the healing process are unknown. Deliaert et al19 postulate that triclosan can react with free chlorine in the wound environment (ie, chlorhexidine wash), leading to the formation of chloroform and other chlorinated by-products, which could have a negative effect on wound healing. Therefore, it may be important to consider the effect of the antibiotic compound on suture integrity before integrating these into standard practice. It is also important to note that the studies which assessed wound healing did not exclude the effect of smoking, a significant confounding factor that can contribute to wound dehiscence and poor outcomes.28,29 Further studies assessing the mechanical integrity of sutures while considering patient risk factors are required to understand whether the use of AISs could have a significant impact on wound healing processes. Despite these promising findings, several limitations must be acknowledged. Most importantly, the small number of studies included in this systematic review limited the analyses that could be performed. For example, stratifying results based on the type of suture material used and dose–response relationships between antimicrobial coating concentration and clinical outcomes would have been helpful in clarifying the differing effects of various antibiotic coatings. Additionally, outcome reporting was inconsistent across studies, particularly for wound cosmetic outcomes, which restricted our ability to perform broader meta-analyses. The included studies did not account for confounding variables such as smoking status, diabetes, or obesity, which could impact postoperative outcomes. Finally, some of the studies included do not fall solely under the domain of plastic surgery. For instance, breast surgery and hernia repair may also fall under the domain of general surgeons, and hand surgery may also fall under the responsibility of orthopedic surgeons. Nevertheless, these studies were retained in our analysis, as these procedures are also performed by plastic surgeons. This variability in our assessment may be perceived as a strength of our study because a range of anatomical areas and procedures were included, demonstrating that our findings are relevant to multiple surgical interventions. Nonetheless, this review contributes meaningfully to the limited current evidence regarding the use of AISs in plastic surgery and suggests a clinically relevant benefit, particularly in reducing infection and improving wound healing. CONCLUSIONS This systematic review and meta-analysis provides preliminary evidence supporting the potential benefits of AISs in SSIs and wound healing outcomes in plastic surgery. However, limitations in study design, sample size, and heterogeneity warrant cautious interpretation, and robust RCTs with large cohorts focused on comparing antimicrobial agents and their utility in different anatomical areas are necessary to obtain a comprehensive understanding of the risks and benefits of AISs in plastic surgery. DISCLOSURES Dr. Janis receives royalties from Thieme Medical Publishers and Springer Publishing. The other authors have no financial interest to declare in relation to the content of this article.